Business Wire

ADVA

2.11.2021 09:02:06 CET | Business Wire | Press release

Share
ADVA launches embedded timing solution for third-party hardware

ADVA (FSE: ADV) today introduced its OSA 5400 SyncModule™ embedded timing solution, enabling technology suppliers to easily integrate precise synchronization into their hardware. The M.2 form factor module offers equipment vendors a way to simply and cost-effectively add crucial timing capabilities with key functionality into their switches, routers, open compute servers and other IT devices. Featuring GNSS, PTP and NTP engines as well as comprehensive PTP and GNSS monitoring and assurance functionality, the OSA 5400 SyncModule empowers third-party companies to leverage the unique expertise of ADVA’s Oscilloquartz synchronization specialists. The solution will provide a major boost to suppliers of mobile infrastructure and white box vendors. It will be key for enabling assured sub-microsecond timing in public and private networks as well as critical infrastructure.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211102005094/en/

“Our OSA 5400 SyncModule brings something completely new and very valuable to the market. For the first time, third-party technology manufacturers will be able to embed the most advanced synchronization capabilities into their designs and easily control them with our Ensemble Sync Director or their own management system,” said Gil Biran, general manager, Oscilloquartz, ADVA. “With our OSA 5400 SyncModule , we’re extending the disaggregated approach to building networks into the area of synchronization. The integrated solution gives vendors the ability to instantly inject the most advanced, highly accurate and fully assured timing into their hardware platforms. As our solution utilizes the widely applied, standardized M.2 interface, integration is simple. It can also easily be added to existing designs.”

The trend towards network disaggregation is accelerating innovation and expanding the market for customers. This does, however, create a challenge for technology suppliers when it comes to synchronization. Now, the OSA 5400 SyncModule is filling that gap. The low-power M.2 module gives vendors of emerging technologies, such as open RAN and next-generation data center hardware, the ability to quickly harness the benefits of an integrated GNSS receiver, PTP, NTP and assurance engines, as well as full sync management functionality. Featuring multiple interface options for easy integration, the OSA 5400 SyncModule comes with an open API for simple configuration. It can also be managed by ADVA’s proven Ensemble Sync Director management system for complete control of the timing infrastructure.

“Cost-effective and hassle-free, our new embedded timing solution brings highly precise and assured synchronization to a whole new market. For companies who are suppliers of 5G RAN hardware or open compute servers, our OSA 5400 SyncModule offers major value,” commented Nir Laufer, VP, product line management, Oscilloquartz, ADVA. “Vendors like those, who are not necessarily experts in network timing, now have the opportunity to instantly pour all of our synchronization know-how into their solutions. And that enables customers to choose the ideal components for their specific needs complete with the best available timing.”

Watch this video to learn more about the OSA 5400 SyncModule : https://youtu.be/iPUl_n0dvJU .

Further information is also available in these slides: https://adva.li/osa-5400-syncmodule-slides .

About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .

About Oscilloquartz

Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to-end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA company, we’re creating new opportunities for tomorrow’s networks. For more information, please visit us at www.oscilloquartz.com .

Published by:

ADVA Optical Networking SE, Munich, Germany

www.adva.com

Social Media:

https://www.facebook.com/ADVAOpticalNetworking

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 15:15:00 CEST | Press release

NVentures, ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures join CapitalG, a16z, Menlo Ventures, and others in backing the high-growth AI infrastructure startup OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leadi

Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press release

Xsolla Adds New Features For Creators, Community Leader Experience, And Distinct Channels For Emerging Markets Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in

Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release

Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar

ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release

First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno

BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release

Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye